PMID- 19171874 OWN - NLM STAT- MEDLINE DCOM- 20090507 LR - 20211028 IS - 1528-0020 (Electronic) IS - 0006-4971 (Linking) VI - 113 IP - 15 DP - 2009 Apr 9 TI - C1q enhances IFN-gamma production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells. PG - 3485-93 LID - 10.1182/blood-2008-06-164392 [doi] AB - Dendritic cells (DCs) are known to produce C1q, the initiator of the classical complement pathway. We demonstrate that murine DCs deficient in C1q (C1qa(-/-)) are poorer than wild-type (WT) DCs at eliciting the proliferation and Th1 differentiation of antigen-specific T cells. These defects result from decreased production of IL-12p70 by C1qa(-/-) DCs and impaired expression of costimulatory molecules CD80 and CD86 in response to CD40 ligation. The defective production of IL-12p70 and the reduced expression of CD80 and CD86 by C1qa(-/-) DCs were specifically mediated via CD40 ligation, as normal levels of IL-12p70 and CD80/86 were observed after ligation of Toll-like receptors (TLRs) on C1qa(-/-) DCs. CD40 ligation on C1qa(-/-) DCs, but not TLR ligation, results in decreased phosphorylation of p38 and ERK1/2 kinases. A strong colocalization of CD40 and C1q was observed by confocal microscopy upon CD40 ligation (but not TLR ligation) on DCs. Furthermore, human DCs from 2 C1q-deficient patients were found to have impaired IL-12p70 production in response to CD40L stimulation. Our novel data suggest that C1q augments the production of IL-12p70 by mouse and human DCs after CD40 triggering and plays important roles in sustaining the maturation of DCs and guiding the activation of T cells. FAU - Baruah, Paramita AU - Baruah P AD - Molecular Genetics and Rheumatology Section, Faculty of Medicine, Imperial College London, London, United Kingdom. FAU - Dumitriu, Ingrid E AU - Dumitriu IE FAU - Malik, Talat H AU - Malik TH FAU - Cook, H Terence AU - Cook HT FAU - Dyson, Julian AU - Dyson J FAU - Scott, Diane AU - Scott D FAU - Simpson, Elizabeth AU - Simpson E FAU - Botto, Marina AU - Botto M LA - eng GR - BB/F020732/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom GR - 071467/WT_/Wellcome Trust/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090126 PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (CD40 Antigens) RN - 0 (Calreticulin) RN - 0 (Toll-Like Receptors) RN - 187348-17-0 (Interleukin-12) RN - 80295-33-6 (Complement C1q) RN - 82115-62-6 (Interferon-gamma) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 1) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 3) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) SB - IM MH - Animals MH - Antigen Presentation/immunology MH - Apoptosis/immunology MH - CD40 Antigens/*metabolism MH - Calreticulin/metabolism MH - Cell Communication/immunology MH - Cell Differentiation/immunology MH - Cells, Cultured MH - Complement C1q/genetics/*metabolism/pharmacology MH - Dendritic Cells/cytology/drug effects/*metabolism MH - Female MH - Humans MH - Interferon-gamma/*metabolism MH - Interleukin-12/metabolism MH - Lymphocyte Transfusion MH - Male MH - Mice MH - Mice, Mutant Strains MH - Mitogen-Activated Protein Kinase 1/metabolism MH - Mitogen-Activated Protein Kinase 3/metabolism MH - Phagocytosis/immunology MH - Spleen/cytology MH - Th1 Cells/*cytology/metabolism MH - Toll-Like Receptors/metabolism MH - p38 Mitogen-Activated Protein Kinases/metabolism EDAT- 2009/01/28 09:00 MHDA- 2009/05/08 09:00 CRDT- 2009/01/28 09:00 PHST- 2009/01/28 09:00 [entrez] PHST- 2009/01/28 09:00 [pubmed] PHST- 2009/05/08 09:00 [medline] AID - S0006-4971(20)39346-0 [pii] AID - 10.1182/blood-2008-06-164392 [doi] PST - ppublish SO - Blood. 2009 Apr 9;113(15):3485-93. doi: 10.1182/blood-2008-06-164392. Epub 2009 Jan 26.